Photo Gallery



News & Updation

  • APRIL 2018 Issue has been successfully launched on 1 April 2018

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.647 to 7.421 due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.



Imad Dawood Saleh*, Haniza Hanim Mohd Zain, Husni Ibrahim, Noman D. Salih, Hanan Kumar Gopalan


This study aimed to develop a novel probiotic, using microorganisms isolated and identified from rabbit‟s colon, for developing a nutritional supplement to maintain and treat the weaken immune system responses in immunocompromised animals. 30 NZW rabbits divided into three groups, the first served as a control, while the other two were induced with Azathioprine (20mg\kg\Day) for two weeks to make them immunocompromised, one of them treated with the probiotic and the other group has left to heal naturally, both were monitored for another two weeks as treatment or healing period. Results indicated that treatment with this probiotic enhanced effectively the immunocompromised rabbits, an improvement of full blood count has indicated in the treated group (5.42±2.20 x109), whereas the non-treated group was (3.20±0.59 x109), compared to control group (9.68±0.30 x109). A significant decrease recorded in lymphocytes percentage of rabbits treated with probiotic (25%), and non-treated (20%) compared to control (66%). Monocytes count has been higher in immunocompromised groups, treated and non-treated (10% and 12% respectively) compared to control (5%). Neutrophils count showed less percentage in non-treated (3%) and treated (2%) compared to control group (23%). These findings declared that the daily uptake of this probiotic has improved significantly the specific and nonspecific immunity of impaired rabbits, caused by the immunosuppressive drug. The study implicated the use of this product could be a basis for further studies to develop a promising commercial product for reducing medical complications caused by an immunosuppressant given to human patients or domesticated animals under certain conditions.

Keywords: Rabbits, Immunosuppression, Probiotic, Flowcytometry.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More